Search

Your search keyword '"Northcott, Paul A"' showing total 85 results

Search Constraints

Start Over You searched for: Author "Northcott, Paul A" Remove constraint Author: "Northcott, Paul A" Database OAIster Remove constraint Database: OAIster
85 results on '"Northcott, Paul A"'

Search Results

1. PRDM6 promotes medulloblastoma by repressing chromatin accessibility and altering gene expression

2. The HHIP-AS1 lncRNA promotes tumorigenicity through stabilization of dynein complex 1 in human SHH-driven tumors

3. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.

4. Medulloblastoma uses GABA transaminase to survive in the cerebrospinal fluid microenvironment and promote leptomeningeal dissemination.

5. Medulloblastomics revisited : biological and clinical insights from thousands of patients

6. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.

7. Pan-cancer analysis of whole genomes

8. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.

9. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.

10. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

11. Pan-cancer analysis of whole genomes

12. Resolving medulloblastoma cellular architecture by single-cell genomics

13. The whole-genome landscape of medulloblastoma subtypes.

14. The whole-genome landscape of medulloblastoma subtypes.

15. Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma.

16. Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma.

17. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

18. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.

19. DNA methylation-based classification of central nervous system tumours

20. DNA methylation-based classification of central nervous system tumours

21. DNA methylation-based classification of central nervous system tumours

22. The landscape of genomic alterations across childhood cancers

23. Deep sequencing of WNT-activated medulloblastomas reveals secondary SHH pathway activation.

24. DNA methylation-based classification of central nervous system tumours

25. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

26. Proteomics, Post-translational Modifications, and Integrative Analyses Reveal Molecular Heterogeneity within Medulloblastoma Subgroups.

27. DNA methylation-based classification of central nervous system tumours

28. The landscape of genomic alterations across childhood cancers

29. DNA methylation-based classification of central nervous system tumours

30. Spectrum and prevalence of genetic predisposition in medulloblastoma:a retrospective genetic study and prospective validation in a clinical trial cohort

31. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs

32. The whole-genome landscape of medulloblastoma subtypes

33. Spectrum and prevalence of genetic predisposition in medulloblastoma:a retrospective genetic study and prospective validation in a clinical trial cohort

34. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking

35. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking

36. The whole-genome landscape of medulloblastoma subtypes

37. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking

38. The whole-genome landscape of medulloblastoma subtypes

39. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.

40. Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.

41. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

42. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

43. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.

44. Medulloblastoma-associated DDX3 variant selectively alters the translational response to stress.

45. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

46. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

47. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

48. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

49. Divergent clonal selection dominates medulloblastoma at recurrence

50. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

Catalog

Books, media, physical & digital resources